Sunway Healthcare Holdings Berhad (SHH) has announced the end of the stabilisation period for its recent initial public offering (IPO), confirming that no stabilising activities were undertaken during the process.
The company said Maybank Investment Bank Berhad, acting as the stabilising manager, confirmed that the stabilisation period ran from 18 March to 17 April 2026, in line with regulatory requirements under Malaysia’s capital markets framework.
Throughout the one-month stabilisation window, the stabilising manager did not intervene in the market to support SHH’s share price. Stabilisation activities, when undertaken, typically involve buying shares in the open market to reduce price volatility following an IPO.
Separately, Maybank Investment Bank said it has fully exercised the over-allotment option, involving a total of 295.35 million shares granted by Sunway City Sdn Bhd and Greenwood Capital Pte Ltd.
Proceeds from the exercise of the option will be returned to the over-allotment option providers, the company added.
The cessation of the stabilisation period marks the completion of post-IPO price support mechanisms, allowing SHH shares to trade fully based on market forces moving forward.
Sunway Healthcare debuted on the Main Market of Bursa Malaysia as part of the broader Sunway Berhad group’s healthcare expansion strategy.
